Cargando…

Metformin- A Promising Agent for Chemoprevention in BRCA1 Carriers

Detalles Bibliográficos
Autores principales:	Kumar, Nagi B., Vadaparampil, Susan T., Mahajan, Nupam, Lilienfeld, Howard S., Lee, Ji-Hyun, Laronga, Christine, Hakam, Ardeshir, Hein, John J., Egan, Kathleen M, Arun, Banu, Pal, Tuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4474476/ https://www.ncbi.nlm.nih.gov/pubmed/26097796 http://dx.doi.org/10.4172/2161-1041.1000104

Ejemplares similares

An Exploratory Study to Determine Whether BRCA1 and BRCA2 Mutation Carriers Have Higher Risk of Cardiac Toxicity
por: Sajjad, Monique, et al.
Publicado: (2017)

Disparities in BRCA counseling across providers in a diverse population of young breast cancer survivors
por: Reid, Sonya, et al.
Publicado: (2020)

The Promise of Piperine in Cancer Chemoprevention
por: Benayad, Salma, et al.
Publicado: (2023)

Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment
por: Campbell, Aideen M, et al.
Publicado: (2018)

Chemopreventive Effect of Metformin on Gastric Cancer Development
por: Cheung, Ka Shing, et al.
Publicado: (2022)

Promising agents for chemoprevention of skin cancer
por: Stratton, S.P., et al.
Publicado: (2006)

Fisetin and Quercetin: Promising Flavonoids with Chemopreventive Potential
por: Kashyap, Dharambir, et al.
Publicado: (2019)

Breast Cancer Metabolism and Mitochondrial Activity: The Possibility of Chemoprevention with Metformin
por: Cazzaniga, Massimiliano, et al.
Publicado: (2015)

Zinc: A promising agent in dietary chemoprevention of cancer
por: Dhawan, D. K., et al.
Publicado: (2010)

Plant Natural Products: Promising Resources for Cancer Chemoprevention
por: Ma, Li, et al.
Publicado: (2021)

Molecular Targeted Therapies Using Botanicals for Prostate Cancer Chemoprevention
por: Kumar, Nagi, et al.
Publicado: (2012)

Chemoprevention with the metabolism modifying drugs dichloroacetate and metformin in Trp53+/- mice
por: Blackburn, AC, et al.
Publicado: (2012)

Survival in Norwegian BRCA1 mutation carriers with breast cancer
por: Hagen, Anne Irene, et al.
Publicado: (2009)

Metformin and the promise of geroprotection
por: Kalra, Sanjay, et al.
Publicado: (2012)

BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Maxwell, Kara N., et al.
Publicado: (2017)

Promising Compounds From Murraya exotica for Cancer Metastasis Chemoprevention
por: He, Su-Dan, et al.
Publicado: (2016)

Antiangiogenic Phytochemicals Constituent of Diet as Promising Candidates for Chemoprevention of Cancer
por: Marrero, Ana Dácil, et al.
Publicado: (2022)

Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based “starvation” strategies in BRCA1 carriers
por: Cuyàs, Elisabet, et al.
Publicado: (2016)

Helping Patients Understand and Cope with BRCA Mutations
por: Makhnoon, Sukh, et al.
Publicado: (2022)

Metformin and Chemoprevention: Potential for Heart-Healthy Targeting of Biologically Aggressive Breast Cancer
por: Jones, Veronica C., et al.
Publicado: (2020)

Cross talk of tyrosine kinases with the DNA damage signaling pathways
por: Mahajan, Kiran, et al.
Publicado: (2015)

ACK1/TNK2 Tyrosine Kinase: Molecular Signaling and Evolving Role in Cancers
por: Mahajan, Kiran, et al.
Publicado: (2014)

Management of the asymptomatic BRCA mutation carrier
por: Teller, Paige, et al.
Publicado: (2010)

Cancer risks among BRCA1 and BRCA2 mutation carriers
por: Levy-Lahad, E, et al.
Publicado: (2007)

Prostate screening uptake in Australian BRCA1 and BRCA2 carriers
por: McKinley, Joanne M, et al.
Publicado: (2007)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018)

Gastric Cancer Risk and Pathogenesis in BRCA1 and BRCA2 Carriers
por: Buckley, Kole H., et al.
Publicado: (2022)

Germline BRCA1/BRCA2 mutations among high risk breast cancer patients in Jordan
por: Abdel-Razeq, Hikmat, et al.
Publicado: (2018)

No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers
por: Møller, Pål, et al.
Publicado: (2007)

Perspective: Chemoprevention of colorectal neoplasia: Translating scientific promise into clinical practice
por: Lance, Peter, et al.
Publicado: (2011)

Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
por: Xia, Hongping, et al.
Publicado: (2017)

Incorporating tumor immunohistochemical markers in BRCA1 and BRCA2 carrier prediction
por: Tai, Yu Chuan, et al.
Publicado: (2008)

Variation in breast cancer risk in BRCA1 and BRCA2 mutation carriers
por: Rebbeck, Timothy R, et al.
Publicado: (2008)

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Ahmed, M, et al.
Publicado: (2010)

Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review
por: Bougie, O., et al.
Publicado: (2011)

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
por: Metcalfe, K, et al.
Publicado: (2011)

Breastfeeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers
por: Kotsopoulos, Joanne, et al.
Publicado: (2012)

Managing BRCA Mutation Carriers in China: Reply
por: Kwong, Ava, et al.
Publicado: (2010)

Selenium and the risk of cancer in BRCA1 carriers
por: Lubinski, J, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_u6n5gddlv3ji63v08cv5bgqsjj